Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

The chip maker posted a big jump in revenue in its data-center business, but the results undershot analysts' r ...

EDEN's concentrated portfolio, with the top 5 holdings making up 42% of the fund, allows for easier tracking and potential ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

The Nasdaq and other major stock market indexes dipped Wednesday after underwhelming earnings reports from Google parent ...

Connected: that’s the word that fits best when we talk about Ireland’s Midlands region. From its place at the heart of ...

Morgan Stanley initiated coverage of Novo Nordisk (NVO) with an Equal Weight rating and DKK 700 price target The firm says near-term U.S.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn ...

We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a ...

By contrast, Novo Nordisk is both the developer and seller of Wegovy, while Viking Therapeutics's VK2735 has posted impressive results in testing and is now in the later stages of development. Wegovy ...